跳至主要内容
临床试验/IRCT20220103053615N1
IRCT20220103053615N1招募中3 期

Comparison of the effectiveness of aripiprazole and risperidone on the psychotic symptoms of methamphetamine use

niversity of social welfare and rehabilitation sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Men and women with written informed consent to enter the trial
  • At least one Positive and Negative Syndrome Scale score equal or greater than 4
  • Methamphetamine use in less than 4 weeks leading to admition
  • No other substance dependencies except for Tobacco
  • diagnosis of Metamphetamin induced psychotic disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition

排除标准

  • Sever nonpsychiatric condition in which Risperidone or Aripiprazole are contraindicated
  • Aripiprazole or Risperidone Allergies
  • Active suicidal or homicidal thoughts
  • Comorbid mood or anxiety disorders
  • Pregnant or nursing women or high suspicion of pregnancy
  • Psychiatric medication use in last 4 weeks other than Benzodiazepines

研究者

发起方
niversity of social welfare and rehabilitation sciences

相似试验